Your session is about to expire
← Back to Search
Antiseptic
Povidone-Iodine Irrigation for Appendicitis (PAPPA Trial)
Phase 4
Waitlist Available
Led By Kuojen Tsao, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Appendectomy performed for acute appendicitis
Be younger than 18 years old
Must not have
Simple or gangrenous appendicitis
Interval or incidental appendectomy
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days post surgery
Awards & highlights
Summary
This trial will compare the rate of postoperative intra-abdominal abscesses and hospital length of stay for patients who receive povidone-iodine irrigation versus usual care.
Who is the study for?
This trial is for children with a confirmed diagnosis of perforated appendicitis who are undergoing an appendectomy at a participating center. It's not for those who tried non-surgical treatment first, have simple or gangrenous appendicitis, are pregnant, or have iodine allergy, thyroid issues, or kidney problems.
What is being tested?
The study is testing if washing out the inside of the abdomen with povidone-iodine (PVI) during surgery can reduce abscesses after operation compared to usual care. The impact on hospital stay and readmissions within 30 days post-surgery will also be evaluated.
What are the potential side effects?
Possible side effects from PVI irrigation may include allergic reactions in those sensitive to iodine and potential effects on thyroid function or kidneys due to iodine absorption.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had my appendix removed due to acute appendicitis.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have been diagnosed with appendicitis.
Select...
I have had my appendix removed, either planned or by chance.
Select...
I have a history of iodine allergy, thyroid issues, or kidney problems.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days post surgery
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days post surgery
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
number of patients with post operative intra-abdominal abscesses
Secondary study objectives
Length of hospital stay(LOS)
Number of patients that are readmitted
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Irrigation with PVIExperimental Treatment1 Intervention
Group II: Usual careActive Control1 Intervention
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
935 Previous Clinical Trials
334,157 Total Patients Enrolled
Kuojen Tsao, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
12 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have been diagnosed with appendicitis.I have had my appendix removed, either planned or by chance.I had my appendix removed due to acute appendicitis.I have a history of iodine allergy, thyroid issues, or kidney problems.I tried treatments other than surgery for over 48 hours after my diagnosis.
Research Study Groups:
This trial has the following groups:- Group 1: Usual care
- Group 2: Irrigation with PVI
Awards:
This trial has 3 awards, including:- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger